首页> Hepatology: Official Journal of the American Association for the Study of Liver Diseases> Serum Cytokine Profiles Predict Survival Benefits in Patients with Advanced Hepatocellular Carcinoma Treated with Sorafenib: a Retrospective Cohort Study

Serum Cytokine Profiles Predict Survival Benefits in Patients with Advanced Hepatocellular Carcinoma Treated with Sorafenib: a Retrospective Cohort Study

导出原文传递

翻译打印收藏纠错

作者： Hayashi, Tomoyuki ^[1] ; Suda, Tsuyoshi ; Yamashita, Taro ; Okada, Hikari ; Asahina, Yoshiro ; Hayashi, Takehiro ; Hara, Yasumasa ; Nio, Kouki ; Terashima, Takeshi ; Sunagozaka, Hajime ; Takatori, Hajime ; Arai, Kuniaki ; Sakai, Yoshio ; Yamashita, Tatsuya ; Mizukoshi, Eishiro ; Honda, Masao ; Kaneko, Shuichi

作者单位： Kanazawa Univ, Grad Sch Med Sci, Gastroenterol, Kanazawa, Ishikawa, Japan ^[1]

发布时间 2020-08-22

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Hepatology

2017年66卷Suppl.1期

401A-401A页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Serum Cytokine Profiles Predict Survival Benefits in Patients with Advanced Hepatocellular Carcinoma Treated with Sorafenib: a Retrospective Cohort Study

Hepatology

相似文献

Hepatology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Serum Cytokine Profiles Predict Survival Benefits in Patients with Advanced Hepatocellular Carcinoma Treated with Sorafenib: a Retrospective Cohort Study

Hepatology

相似文献

Hepatology

相关期刊

检索历史清除